Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · SkinHealth Systems Inc. (SKIN)

SkinHealth Systems Q3 net sales fall 2.1% to $69.2 million; net loss narrows

Mixed Impact 3 of 5 earnings Written later

SkinHealth Systems reported third-quarter 2026 net sales of $69.2 million, down 2.1% from a year earlier, as delivery system sales fell. Net loss narrowed to $0.9 million from $11.0 million, and adjusted EBITDA rose to $13.4 million from $8.9 million. The company also updated its fiscal 2026 guidance to net sales of $281 million to $287 million and adjusted EBITDA of $48 million to $50 million, citing continued pressure on sales.

Key points

  • Q3 2026 net sales were $69.2 million versus $70.7 million in Q3 2025; delivery systems placed fell to 798 from 875.
  • Net loss was $0.9 million in Q3 2026 versus $11.0 million in Q3 2025; adjusted EBITDA was $13.4 million versus $8.9 million.
  • Updated fiscal 2026 guidance: net sales of $281 million to $287 million and adjusted EBITDA of $48 million to $50 million.
  • Cash, cash equivalents and restricted cash were about $112 million at September 30, 2026, versus about $233 million at December 31, 2025, after the 2026 notes were retired.

The filing

CompanySkinHealth Systems Inc. (SKIN)
Form8-K, current report
Filed with the SECNov 5, 2026, 4:13 PM ET
Accession number0001628280-26-071066

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.